Lanreotide Autogel 120 mg
A-38-52030-214
Approved small_molecule completed
Quick answer
Lanreotide Autogel 120 mg for Acromegaly is a Approved program (small_molecule) at Ipsen with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ipsen
- Indication
- Acromegaly
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed